Article

NEI's first director dies

Carl Kupfer, MD, who directed the National Eye Institute (NEI) of the National Institutes of Health (NIH) for 30 years, died April 7 after a long illness.

Bethesda, MD-Carl Kupfer, MD, who directed the National Eye Institute (NEI) of the National Institutes of Health (NIH) for 30 years, died April 7 after a long illness. He was 83.

Dr. Kupfer was appointed the first director of the NEI in 1970 after Congress established the institute. During his tenure, the institute’s budget grew from $24 million to more than $450 million.

He stepped down from the position in 2000 but remained active in vision research by compiling the Cogan Collection, a series of clinical cases and pathology reports of more than 50,000 patients. Dr. Kupfer also authored History of the National Eye Institute, 1968-2000, which chronicled the inception of the institute and its growth during his tenure.

Under his leadership, the NEI research program was expanded to include areas such as molecular biology, immunology, neuroscience, and molecular genetics. Dr. Kupfer also supported the visual processing program within the NEI intramural program, which has become a “crown jewel of visual neuroscience,” according to the institute.

Basic research also thrived under Dr. Kupfer, according to the NEI. Investigators identified genes associated with juvenile primary open-angle glaucoma, age-related macular degeneration (AMD), retinitis pigmentosa, and retinoblastoma. They also developed medical lasers to treat diabetic retinopathy, AMD, and nearsightedness, as well as safe and effective techniques to photograph the eye. During his tenure, the NEI research portfolio grew to include more than 1,600 investigators at universities, medical centers, and research institutions around the United States.

Dr. Kupfer also oversaw the development of the National Eye Health Education Program, a partnership of professional, civic, and volunteer organizations, as well as government agencies formed to educate the public and professionals about eye health.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
© 2025 MJH Life Sciences

All rights reserved.